🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s NVAX Holdings & Trades

First Buy
Q3 2020
Duration Held
10 Quarters
Largest Add
Q3 2020
+597,419 Shares
Current Position
16,435 Shares
$110,443 Value

Steven Cohen's NVAX Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 16,435 shares of Novavax, Inc. (NVAX) worth $110,443, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 10 quarters.

Based on 13F filings, Steven Cohen has maintained a strategic position in NVAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 96,917 shares. Largest reduction occurred in Q4 2020, reducing 534,019 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Novavax (NVAX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Novavax (NVAX) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -80,482 Reduce 83.04% 16,435 $6.72
Q3 2025 +96,917 New Buy 96,917 $8.67
Q3 2023 -3,194 Sold Out 0 $0.00
Q2 2023 +3,194 New Buy 3,194 $7.43
Q3 2022 -500 Sold Out 0 $0.00
Q2 2022 +500 New Buy 500 $52.00
Q2 2021 -83,800 Sold Out 0 $0.00
Q1 2021 +20,400 Add 32.18% 83,800 $181.31
Q4 2020 -534,019 Reduce 89.39% 63,400 $111.51
Q3 2020 +597,419 New Buy 597,419 $108.35

Steven Cohen's Novavax Investment FAQs

Steven Cohen first purchased Novavax, Inc. (NVAX) in Q3 2020, acquiring 597,419 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Novavax, Inc. (NVAX) for 10 quarters since Q3 2020.

Steven Cohen's largest addition to Novavax, Inc. (NVAX) was in Q3 2020, adding 597,419 shares worth $64.73 M.

According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 16,435 shares of Novavax, Inc. (NVAX), valued at approximately $110,443.

As of the Q4 2025 filing, Novavax, Inc. (NVAX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Novavax, Inc. (NVAX) was 597,419 shares, as reported at the end of Q3 2020.